1L Durvalumab (D) plus Platinum-Etoposide (EP) in Patients with advanced small cell Lung Cancer (ES-SCLC): Exploratory Analysis of SCLC molecular Subtypes in the CASPIAN Trial

Schulz, Christian and Xie, M. and Chugh, P. and Broadhurst, H. and Lai, Z. and Whitston, D. and Paz-Ares, L. and Gay, C. and Byers, L. and Rudin, C. M. and Stewart, R. and Barrett, J. C. and Shrestha, Y. and Panse, J. (2022) 1L Durvalumab (D) plus Platinum-Etoposide (EP) in Patients with advanced small cell Lung Cancer (ES-SCLC): Exploratory Analysis of SCLC molecular Subtypes in the CASPIAN Trial. In: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 11 Oct 2023 07:00
Last Modified: 11 Oct 2023 07:00
URI: https://pred.uni-regensburg.de/id/eprint/57980

Actions (login required)

View Item View Item